Nationality
Canadian and American

Year of Birth
1958

• M.D. - Queen’s University, 1983 (Kingston, Canada)

• M.Sc. - California Institute of Technology, Biology, 1989 (Pasadena, USA)

• Ph.D. - University of California, San Francisco, Neuroscience, 1994 (San Francisco, USA)

• Postdoctoral fellow - Stanford University, Biochemistry, 1994-1998 (Stanford, USA)

1984-1987
Harvard Medical School (Boston, USA), Resident in Neurology

1987
Harvard Medical School (Boston, USA), Chief Resident in Neurology

1989-1998
University of California, San Francisco (San Francisco, USA), Adjunct Clinical Appointment in the Department of Neurology

1997-2006
Co-founder, President and CEO of Cytokinetics

2008-2010
President and CEO of Arete Therapeutics

2010-2013
Global Head and Vice President of Genentech Partnering, USA

2013-2018
Global Head and Senior Vice President of Genentech Partnering, USA

Since 2018
Global Head of Pharma Partnering, Roche Basel, Switzerland

Since 1998
Member of Scientific Advisory Board at Cytokinetics

2007-2008
Executive Chairman of the Board of Directors of Cytokinetics

2008-2010
Chairman of the Board of Directors of Cytokinetics

2005-2016
Member of the Board of Directors of HopeLab

2015-2016
Member of the Board of Directors of California Life Sciences Association

2016-2020
Member of the Board of Directors of Coalition for the Life Sciences

since April 2019
Member of the Board of Directors of Chugai Pharmaceutical Co., Ltd.